Skip to content

Glycaemic Index of Fibre-rich Flours in Healthy Volunteers

Study of the Glycaemic Index of Breads Made From Flour Naturally Rich in Fibre in Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05372666
Enrollment
20
Registered
2022-05-13
Start date
2022-06-01
Completion date
2022-11-08
Last updated
2023-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The project aims to evaluate the glycaemic index of breads from different types of flour. In particular, we aim to understand the glycaemic and insulin responses as well as satiety and sensory profiles of the products.

Interventions

OTHERStandard white bread

Bread to be consumed within 10 minutes after 10h fasting

OTHERExperimental white bread

Bread to be consumed within 10 minutes after 10h fasting

OTHERStandard High-fiber bread

Bread to be consumed within 10 minutes after 10h fasting

OTHERExperimental High-fiber bread

Bread to be consumed within 10 minutes after 10h fasting

Sponsors

Institut Polytechnique UniLaSalle
CollaboratorUNKNOWN
Paulic Meunerie SA
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Latin square randomization for test products following reference treatment (as per standard protocol)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Having a Body Mass Index (BMI) between 18.5 and 30 kg/m² * Non-smoker for more than three months * Having signed the informed consent form * Likely to follow the constraints generated by the study (one morning per week for 9 weeks) * Social insurance

Exclusion criteria

* Pregnant woman * Subject with a known progressive somatic or psychiatric disease * Fasting blood glucose greater than 6.1 mmol/L (1.10 g/L), postprandial blood glucose greater than 7.7 mmol/L (1.4 g/L) or known diabetes treated or untreated * Hyperinsulinemia or a history of insulinoma * HbA1c greater than 7 % * History of hypercholesterolemia, hypertension, diabetes or glucose intolerance * History of food allergy or digestive pathology likely to affect digestion or absorption * Renal failure * ASAT or ALAT elevation beyond 1.5 times the upper limit * Subject consuming more than three glasses per day of alcohol or suffering from various addictions * Weight change of more than 3 kg in the last three months * Person participating in another clinical study, or in a period of exclusion from another study * Person deprived of liberty or under judicial protection

Design outcomes

Primary

MeasureTime frameDescription
Glycaemic indexglycemia measured over 120 minutespercentage area under the curve compared to standard white bread as 100% reference

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026